South America emerges as surprise leader in global Covid vaccine race

South America is the world’s most vaccinated region with 63.3 per cent of the population fully jabbed

Gram Slattery
Tuesday 28 December 2021 13:19
Comments
<p>A person receives a Covid vaccine in Rio de Janeiro, Brazil</p>

A person receives a Covid vaccine in Rio de Janeiro, Brazil

Throughout much of 2020 and early 2021, South America was ground zero in the global fight against Covid.

Oxygen ran low in Peru. Gravediggers worked through the night in Sao Paulo, Brazil. Bodies were stuffed into shipping containers in Guayaquil, Ecuador.

Brazil, the largest country in Latin America, saw its coronavirus death toll rise to the second-highest in the world, while Argentina and Peru reported some of the heaviest death per capita figures anywhere.

But in recent months, despite patchy health services and lower income levels than in Europe or the United States, the region has emerged as a surprise winner in the vaccination race.

South America is now the most vaccinated region in the world, with 63.3 per cent of the population fully inoculated, according to the Our World in Data project, which collects official numbers from governments worldwide.

Europe comes in second with 60.7 per cent. In Africa, just 8.8 per cent of the population has completed a full vaccination regimen.

Infection and death rates have plummeted compared to the middle of the year when Latin America and the Caribbean accounted for almost half of global deaths and infections. Now it is Europe where – due to the spread of the Omicron variant – contagion is rebounding.

Epidemiologists point to several factors to explain the speedy vaccination drive. But the most important, they say, has been decades of successful inoculation campaigns that have created the infrastructure needed to deliver jabs en masse, while instilling trust among the population.

In Brazil, successful inoculation drives in the last half century against smallpox, meningitis, polio and measles means that very few people are opposed to vaccines, said Paulo Lotufo, an epidemiologist and professor at the University of Sao Paulo.

In some major cities, including Rio de Janeiro and Sao Paulo, over 99 per cent of the adult population has received at least one dose, authorities say. Brazilians commonly claim with pride that the nation has a “cultura de vacinacao,” or “vaccine culture”.

The same can be said for several other nations in the region, which have previously launched expansive inoculation campaigns after traumatic infectious disease outbreaks in recent decades.

“This confidence, built up over several years, is based on the benefits of our extensive vaccination schedule,” said Leda Guzzi, a Buenos Aires-based infectious disease expert.

Effective public health messaging has been key, too, said Albert Ko, a professor at the Yale School of Public Health and a collaborating researcher at Rio de Janeiro’s Oswaldo Cruz Foundation.

In Brazil, for instance, a mascot resembling a docile white droplet, known as Ze Gotinha, has been heavily used by health officials to promote the vaccine, even as president Jair Bolsonaro has himself declined to be jabbed.

Bolsonaro poses with the Covid vaccine mascot Ze Gotinha in Brasilia

Earlier this year, musician MC Fioti released a viral video with a modified version of one of his hits in association with the Butantan biomedical institute in Sao Paulo promoting the vaccine.

The region, however, is far from out of the woods, particularly as the Omicron variant spreads across the globe.

Even with an impressive 63.3 per cent of the population vaccinated, the region remains below the threshold that most scientists say is needed to offer mass protection. Omicron is now raging in much of Europe despite similar levels of inoculation.

Among children, vaccination rates also vary dramatically from country to country in Latin America, with authorities in Mexico and Brazil relatively slow to approve shots for minors.

Another potential issue is the vaccines used.

Many countries, such as Chile, Uruguay and Brazil, relied heavily on Coronavac, a vaccine produced by China’s Sinovac Biotech Ltd, particularly in the initial phase of their vaccination drives.

While the vaccine is credited with getting jabs into arms quickly, its efficacy is lower than that of its peers, and at least one initial study has indicated it may not produce antibodies against the Omicron variant. Earlier in December, the World Health Organisation (WHO) said that recipients of Sinovac – as well as all other “inactivated” vaccines – should get boosted.

Epidemiologists also say that Omicron may be more adept at dodging the immunity generated by previous Covid infections. That could be bad news in a region where the virus ripped through entire neighbourhoods in earlier stages of the pandemic.

“Many people, particularly in vulnerable communities in Brazil, have been infected,” said Ko, the Yale epidemiologist. “We see this virus infecting people who had already gotten infected before.”

Reuters

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in